title: TGF-beta enhances effector Th1 cell activation but promotes self-regulation via IL-10.
abstract: Myelin-specific effector Th1 cells are able to perpetuate CNS inflammation in experimental autoimmune encephalomyelitis, an animal model representative of multiple sclerosis. Although the effects of cytokines in the CNS microenvironment on naive CD4(+) T cells have been well described, much less is known about their ability to influence Ag-experienced effector cells. TGF-beta is a multifunctioning cytokine present in the healthy and inflamed CNS with well-characterized suppressive effects on naive T cell functions. However, the effects of TGF-beta on effector Th1 cells are not well defined. Using myelin-specific TCR transgenic mice, we demonstrate that TGF-beta elicits differential effects on naive versus effector Th1 cells. TGF-beta enhances cellular activation, proliferation, and cytokine production of effector Th1 cells; however, adoptive transfer of these cells into naive mice showed a reduction in encephalitogenicity. We subsequently demonstrate that the reduced encephalitogenic capacity is due to the ability of TGF-beta to promote the self-regulation of Th1 effector cells via IL-10 production. These data demonstrate a mechanism by which TGF-beta is able to suppress the encephalitogenicity of myelin-specific Th1 effector cells that is unique from its suppression of naive T cells.
authors.affiliation: Department of Molecular Virology, Immunology, and Medical Genetics, Ohio State University Medical Center, Columbus, OH 43210, USA.
authors.forename: David J
authors.initials: DJ
authors.lastname: Huss
authors.forename: Ryan C
authors.initials: RC
authors.lastname: Winger
authors.forename: Haiyan
authors.initials: H
authors.lastname: Peng
authors.forename: Yuhong
authors.initials: Y
authors.lastname: Yang
authors.forename: Michael K
authors.initials: MK
authors.lastname: Racke
authors.forename: Amy E
authors.initials: AE
authors.lastname: Lovett-Racke
mesh_terms: D000818:Animals; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology / Q000378:metabolism / Q000473:pathology; D002454:Cell Differentiation / Q000276:immunology; D049109:Cell Proliferation; D002478:Cells, Cultured; D016207:Cytokines / Q000037:antagonists & inhibitors / Q000096:biosynthesis / Q000502:physiology; D004195:Disease Models, Animal; D004681:Encephalomyelitis, Autoimmune, Experimental / Q000276:immunology* / Q000473:pathology / Q000517:prevention & control; D006131:Growth Inhibitors / Q000037:antagonists & inhibitors / Q000096:biosynthesis / Q000502:physiology; D018836:Inflammation Mediators / Q000502:physiology; D016753:Interleukin-10 / Q000037:antagonists & inhibitors / Q000096:biosynthesis / Q000502:physiology*; D008213:Lymphocyte Activation / Q000276:immunology*; D051379:Mice; D008810:Mice, Inbred C57BL; D008822:Mice, Transgenic; D011948:Receptors, Antigen, T-Cell / Q000235:genetics; D018417:Th1 Cells / Q000276:immunology* / Q000378:metabolism / Q000637:transplantation; D053773:Transforming Growth Factor beta1 / Q000502:physiology*; D015854:Up-Regulation / Q000276:immunology*
chemical_list: D016207:Cytokines; D006131:Growth Inhibitors; D018836:Inflammation Mediators; D011948:Receptors, Antigen, T-Cell; D053773:Transforming Growth Factor beta1; D016753:Interleukin-10
references.citation: J Immunol. 2005 May 15;174(10):5950-8
references.pmid: 15879087
references.citation: Neuron. 2006 Oct 5;52(1):61-76
references.pmid: 17015227
references.citation: J Exp Med. 2009 May 11;206(5):1009-17
references.pmid: 19414553
references.citation: Nat Immunol. 2007 Dec;8(12):1372-9
references.pmid: 17994023
references.citation: J Immunol. 2002 Oct 15;169(8):4183-9
references.pmid: 12370347
references.citation: J Immunol. 1991 May 1;146(9):3012-7
references.pmid: 1707929
references.citation: Cell. 1993 Feb 26;72(4):551-60
references.pmid: 7679952
references.citation: Immunity. 2004 Nov;21(5):719-31
references.pmid: 15539157
references.citation: J Neurosci. 2007 Oct 17;27(42):11201-13
references.pmid: 17942715
references.citation: J Exp Med. 2003 Dec 15;198(12):1875-86
references.pmid: 14676299
references.citation: J Exp Med. 2008 Nov 24;205(12):2887-98
references.pmid: 19001136
references.citation: Science. 1990 Feb 9;247(4943):718-21
references.pmid: 1689076
references.citation: J Exp Med. 2003 Oct 20;198(8):1179-88
references.pmid: 14557415
references.citation: Nature. 1992 Oct 22;359(6397):693-9
references.pmid: 1436033
references.citation: J Exp Med. 2002 Jun 3;195(11):1499-505
references.pmid: 12045248
references.citation: J Immunol. 2008 Mar 1;180(5):2830-8
references.pmid: 18292504
references.citation: Immunity. 2009 Jan 16;30(1):92-107
references.pmid: 19119024
references.citation: Immunity. 2009 Aug 21;31(2):209-19
references.pmid: 19646904
references.citation: Diabetes. 2008 Oct;57(10):2684-92
references.pmid: 18689691
references.citation: Proc Natl Acad Sci U S A. 1991 Apr 1;88(7):2918-21
references.pmid: 2011600
references.citation: J Clin Invest. 1998 Feb 15;101(4):725-30
references.pmid: 9466965
references.citation: Nat Immunol. 2007 Dec;8(12):1390-7
references.pmid: 17994024
references.citation: Development. 1991 Sep;113(1):183-91
references.pmid: 1764993
references.citation: Rev Neurol (Paris). 1991;147(12):763-81
references.pmid: 1780606
references.citation: J Immunol. 1998 Oct 1;161(7):3299-306
references.pmid: 9759845
references.citation: J Exp Med. 1986 May 1;163(5):1037-50
references.pmid: 2871125
references.citation: J Exp Med. 2007 Feb 19;204(2):285-97
references.pmid: 17283207
references.citation: J Immunol. 2007 Feb 1;178(3):1341-8
references.pmid: 17237380
references.citation: Annu Rev Immunol. 2001;19:683-765
references.pmid: 11244051
references.citation: Neurology. 1998 Jul;51(1):289-92
references.pmid: 9674825
references.citation: Neuroscience. 1991;44(3):613-25
references.pmid: 1754055
references.citation: Brain Res. 1992 Aug 7;587(2):216-25
references.pmid: 1525658
references.citation: Eur J Immunol. 1994 Jun;24(6):1434-40
references.pmid: 7515815
references.citation: J Neurosci Res. 1996 Sep 15;45(6):735-46
references.pmid: 8892085
references.citation: Ann Neurol. 1994 Sep;36(3):379-86
references.pmid: 8080246
references.citation: J Immunol. 1992 Apr 1;148(7):2109-17
references.pmid: 1347550
references.citation: J Exp Med. 2009 Aug 3;206(8):1755-67
references.pmid: 19635862
references.citation: Nat Rev Immunol. 2007 Jun;7(6):425-8
references.pmid: 17525751
references.citation: J Clin Invest. 2009 Dec;119(12):3678-91
references.pmid: 19884657
references.citation: J Exp Med. 1997 Jul 7;186(1):159-64
references.pmid: 9207010
references.citation: Cancer Immun. 2004 Jul 23;4:6
references.pmid: 15270555
references.citation: J Cell Biol. 1992 Apr;117(2):395-400
references.pmid: 1560032
references.citation: J Immunol. 1994 Jun 15;152(12):6003-10
references.pmid: 8207225
references.citation: Nat Immunol. 2007 Dec;8(12):1380-9
references.pmid: 17994022
references.citation: Annu Rev Immunol. 2006;24:99-146
references.pmid: 16551245
references.citation: Neurology. 1994 Aug;44(8):1523-6
references.pmid: 8058164
references.citation: J Immunol. 1991 Sep 15;147(6):1792-6
references.pmid: 1716279
references.citation: J Neuroimmunol. 1997 Jul;77(1):45-50
references.pmid: 9209267